Adoptive Therapy Using Antigen-Specific CD4 T-Cells
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn about the safety of giving CD4+T cells
with ipilimumab and cyclophosphamide.
CD4+T cells are a type of white blood cell. Researchers grow the T cells in the laboratory,
and they are designed to find cancer cells and may kill them.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)